Evidence map›Paper›PMID 33671889›Full record

ArticleAntibiotics (Basel, Switzerland)2021

The Human Gut Microbe

Miad Elahi, Haruyuki Nakayama-Imaohji, Masahito Hashimoto, Ayano Tada, Hisashi Yamasaki, Tamiko Nagao, Tomomi Kuwahara

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Veterinary sciences · 2026
    Article
  4. Phylogenomics and Antimicrobial Resistance of ClinicalAntibiotics (Basel, Switzerland) · 2025
    Article
  5. Unravelling three-way interactions betweenJournal of medical microbiology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Miad ElahiDepartment of Microbiology, Faculty of Medicine, Kagawa University, 1750-1 Miki, Kagawa 761-0793, Japan.
Haruyuki Nakayama-ImaohjiDepartment of Microbiology, Faculty of Medicine, Kagawa University, 1750-1 Miki, Kagawa 761-0793, Japan.
Masahito HashimotoDepartment of Chemistry, Biotechnology, and Chemical Engineering, Kagoshima University, Kagoshima 890-8580, Japan.
Ayano TadaDepartment of Microbiology, Faculty of Medicine, Kagawa University, 1750-1 Miki, Kagawa 761-0793, Japan.
Hisashi YamasakiDivision of Biology, Hyogo College of Medicine, Mukogawa, Nishinomiya 663-8501, Japan.
Tamiko NagaoDepartment of Science for Human Health Welfare Care Major, Shikoku University Junior College, Ohjin, Tokushima 771-1192, Japan.
Tomomi KuwaharaDepartment of Microbiology, Faculty of Medicine, Kagawa University, 1750-1 Miki, Kagawa 761-0793, Japan.
Kagawa University · JPHyogo Medical University · JPKagoshima University · JPShikoku University · JP

Funding

Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) KAKEN 20H04125
6 · The paper itself

Abstract

Disruption of the human gut microbiota by antibiotics can lead to

Indexed as

autolysisBacteroides thetaiotaomicroncell wallClostridium difficiletoxin

Identifiers

PMID33671889
PMCPMC7918992
OpenAlexW3129837535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.